Emcure Pharma shares get an upgrade driven by strong prospects in India, Canada

Share it

Despite the 17% correction from its recent highs, shares of Emcure Pharma are trading above their IPO price of ₹1,008.

Leave a Comment

Your email address will not be published. Required fields are marked *